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Abstract
Problem: Asthma affects one out of every ten children in the United States. It is recommended
that children with persistent asthma take long-term controller (LTC) medications to achieve
control. However, adherence varies, and many children do not take their LTC medication at all.
The average cost for hospitalization of a child with asthma is $8,406. Asthma in children also
contributes to school absenteeism and a decrease in quality of life.
Objective: A literature review was performed to examine factors that affect adherence to LTC
medications used to control asthma in children.
Method: A literature review was performed using the CINAHL, ERIC, Medline, Psych Info, and
Academic Search Premier databases. Keywords included asthma AND child* OR pediatric*
AND adherence OR compliance AND corticosteroid* OR “leukotriene modifier*” OR “mast
cell stabilizer*” OR “monoclonal antibod*” OR “long-acting beta agonist.*” After applying
exclusion criteria 35 articles were included in this review.
Results: A variety of factors that affect adherence were identified. Internal factors included age,
sex, and race/ethnicity. External factors included socioeconomic status, environment, health
perception, lack of motivation, parental education, disease/medication beliefs, family dynamics
and planning, responsibility, severity, and exacerbations. Interventional factors included
caregiver-family communication, asthma knowledge, specialty care, white coat adherence,
number of prescriptions, asthma action plans, medication regimens, and technology.
Conclusion: It is recommended that healthcare providers use a four-step process during inpatient
and outpatient asthma visits. The steps include assess and educate, collaborate, problem-solve,
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and follow-up. Collectively, this method can help healthcare providers overcome many of the
barriers that were identified.
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Introduction
Pathophysiology
Symptoms exhibited by people with asthma are a manifestation of underlying
inflammatory processes. The airways of people with asthma contain excessive amounts of
inflammatory cells including: mast cells, eosinophils, neutrophils, and macrophages. These cells
and many others have been identified in the pathophysiology of asthma. Immunoglobin E (IgE)
are antibodies that are abundant during allergic responses that may trigger asthma. They activate
other cells including mast cells. Mast cells contribute to bronchoconstriction. Smaller airways
decrease the amount of air that is able to traverse through the bronchioles (National Heart, Lung,
and Blood Institute [NHLBI], 2007.
Macrophages in the airways are also activated by IgE antibodies, and they increase
inflammation. Eosinophils and epithelial cells that line the airways also contribute to
inflammation. The inflammation can have a negative effect on the smooth muscle in the airways
causing hypertrophy which may decrease the size of the airways and contractions that can
obstruct airflow (NHLBI, 2007).
Inflammation involved in the pathophysiology of asthma is complex and not fully
understood. What is understood is that inflammation contributes to bronchoconstriction, airway
hyper-responsiveness and obstruction. This causes the hallmark symptoms of asthma which are
coughing, wheezing, breathlessness, and chest tightness. Over time, permanent changes to the
airway, known as airway remodeling, can also occur (NHLBI, 2007).
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Asthma Today
According to the most recent data, there are 25.7 million people in the United States that
have asthma, and its incidence is increasing. It is more common among women than men, and is
more prevalent in the poor. There is also racial disparity with 16% of Porto Ricans, 11% of
blacks, 8% of whites, and 5% of Mexicans having asthma.
In one year, asthma accounted for more than 10 million outpatient visits, more than 2
million emergency department (ED) visits, and more than 450,000 hospital admissions (National
Center for Health Statistics [NCHS], 2012).
There are seven million children in the United States that currently have asthma. It is
more prevalent among boys than girls. Children account for more ED visits and hospitalizations
than adults even though the number of adults with asthma far surpass that of children. More than
half of the children with asthma had an exacerbation in the year preceding data collection. More
than half of the children also missed school due to the disease (NCHS, 2012).
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Background
The most recent guidelines for the diagnosis and treatment of asthma were published by
the NHLBI in 2007. According to these guidelines, the purpose of asthma treatment is to
achieve specific goals. The first goal is to prevent symptoms such as coughing, wheezing, and
shortness of breath. The second goal is to reduce the use of rescue medications to less than two
times per week. The third goal is to maintain lung function as close to normal as is possible.
The fourth goal is to maintain normal physical activity. The fifth goal is to prevent
exacerbations and subsequent ED visits or hospitalizations. The next goal is to prevent any
lessening in lung growth. The final goal is to provide optimal therapy with minimal side effects.
Healthcare providers (HCPs) can determine if these goals are met when they assess asthma
control.
Asthma control is classified as “well-controlled,” “not well-controlled,” or “poorly
controlled.” For children, control is based on frequency of symptoms, frequency of nighttime
awakening, frequency of rescue medication use, frequency of exacerbations that require oral
corticosteroids, and how much symptoms interfere with physical activity (NHLBI, 2007).
For children above the age of five, control is also based on an objective assessment of
lung function. For children above the age of 12, control is also based on data collected in a
questionnaire. Optimally, asthma should be well-controlled. The regimen used to control
asthma also depends on disease severity (NHLBI, 2007).
Asthma can be further classified based on disease severity. Asthma severity is classified
as either intermittent or persistent. Persistent asthma is further classified as “mild,” “moderate,”
or “severe.” Severity is based on the same parameters used to determine asthma control. The
3

best way to control persistent asthma is by incorporating the use of long-term controller (LTC)
medications into the plan of care. LTC medications are taken regularly to prevent exacerbations
and improve control (NHLBI, 2007).
Guidelines identify several medications that are indicated for long-term control of
asthma. All medications have some effect on inflammatory processes. The first and most
effective class of medications include the inhaled corticosteroids (ICSs). They are not the same
as the oral corticosteroids which produce a systemic effect (NHLBI, 2007).
The next class of medications are mast cell stabilizers including cromolyn sodium and
nedocromil. They are used as alternative medications, and are not preferred therapies. The next
class of medications are the immunomodulators. Included in this class is omalizuab which is a
monoclonal antibody. This class is only recommended if other regimens are unsuccessful
(NHLBI, 2007).
The next classification of medications are the leukotriene modifiers. These medications
are also designated for use as alternative medications, and are not preferred therapies. The next
classification includes inhaled long-acting beta2 agonists (LABAs). They are not recommended
as monotheraphy, and should be used in conjunction with another medication (NHLBI, 2007).
The final classification of medications are methylxanthines including theophylline.
Again it is suggested that these medications be used as an alternative, and not preferred therapy.
These medications are used to control persistent asthma and achieve therapeutic goals (NHLBI,
2007).
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Problem
Poor Adherence
Many children with asthma do not take their medication at all. Statistical data collected
by the NCHS in 2012 determined that 60% of children with asthma had persistent asthma.
Another 38% of children with asthma had uncontrolled asthma. Only 40% reported that they had
used a LTC medication in the three months prior to data collection, and 19% overused rescue
medications.
This was consistent with data collected in 2011 when Arellano, Arana, Wentworth,
Vidaurre, and Chipps evaluated prescription fill patterns for 659,159 children with asthma. They
determined that 40% of the participants never received their initial prescription. Children in this
study were between the ages of 6-18, and all of them were insured. This is also consistent with a
study published by Wijga et al. in 2014. Parents of 229 children with asthma participated in the
study. There were 170 children who were taking ICSs. In a questionnaire given to parents it was
determined that 15% of parents avoided giving their child the medication, and another 25% of
parents discontinued the medication.
Schultz et al. (2012) determined that when caregivers report adherence it is unreliable.
They monitored medication adherence in 132 children with asthma using inhalers with electronic
monitoring capability. Adherence was as low as 0% and as high as 100%. Generally, parents
who reported that they missed doses missed at least half of them. Also, parents that reported that
they did not miss any doses missed at least 20% of them.
Duchame et al. (2012) reported that when medication is used to control asthma, it is not
used consistently with caregivers only claiming 51% of their child’s ICSs. In 2014, Mosnaim et
5

al. electronically monitored adherence in minority children with asthma. They found that 76%
did not even take half of their prescribed doses. Chan et al. (2015) showed that adherence in
children taking ICSs was as low as 8%. Inconsistent adherence was also observed by Al-Muhsen
et al. (2015) when they interviewed the caregivers of 297 children with asthma in an ED.
Seventy-three percent of the caregivers reported that they stopped giving their child ICSs when
symptoms improved.
Al-Muhsen et al. (2015) found that 40% of caregivers either started or increased the
dosage of ICSs when their child was having an exacerbation. This was also observed by Wijga
et al. in 2014. Forty percent of caregivers only gave their child ICSs when their child was
symptomatic. This was also observed by Sloan, Gebretsadik, Wu, Michel, and Hartert (2012).
They evaluated prescription fill patterns among children with asthma. Their data showed that
there was a trend in which ICSs were obtained at the same time that caregivers were obtaining
rescue medications used to treat an exacerbation. Poor adherence is problematic because it can
contribute to poor control.
Poor Adherence and Poor Control
In 2014, Baddar, Jayakrishnan, and Al-Rawas examined asthma control in 218
participants. They found that 83% of the participants that had poor medication adherence also
had poor asthma control. This was supported by Klok, Kaptein, Duiverman, and Brand in 2014
who electronically monitored adherence in 81 children with asthma, and determined that children
with well-controlled asthma had a median adherence above 80%.
In 2015, Al-Muhsen et al. found that if caregivers started or increased ICS usage when
their child was having an exacerbation, that child was three times more likely to have
6

uncontrolled asthma. Children who were not taking an ICS were also more likely to have
uncontrolled asthma. Poor medication adherence and the resulting poor control contribute to
increased healthcare utilization including emergency services.
Poor Adherence/Poor Control and the Corresponding Increase in Healthcare Utilization
Emergency department.
Deis, Spiro, Jenkins, Buckles, and Arnold (2010) found that medication adherence was a
factor in ED utilization. They included caregivers of 108 children with persistent asthma. When
asked about their use of ICSs 49% percent of caregivers reported that they did not use ICSs
daily.
Rust, Zhang, and Reynolds (2013) evaluated the ratio of LTC medications to total asthma
medications and its effect on ED utilization among children with asthma covered by Medicaid.
Children who used more rescue medications were 21% more likely to have an ED visit and 70%
more likely to be admitted than children who used more LTC medications than rescue
medications.
Supporting evidence was provided by Al-Muhsen et al. (2015) who found that children
with uncontrolled asthma visited the ED more that those with controlled asthma. Despite this,
the majority of caregivers were not giving their child the medication necessary to achieve
control. Emergency department utilization remains a costly problem for children with asthma.
Costs of emergency department.
Wang, Srebotnjak, Brownell, and Hsia published data in 2014 that determined just how
costly. They received data from almost 3 million ED visits in which costs ranged from $19 to
$12,601. Participants were between the ages of 0-85. Yet, children between the ages of 0-19
7

made up 48% of the sample. The average costs for an ED visit among children with asthma are
displayed in Table 1.

Average Cost for Emergency Department Visits
by Insurance Type in Children Aged 0-19
Medicare
Medicaid
Uninsured
Private
$414
$1,108
$1,120
$1,263
Table 1 ED Costs

Hospitalization.
Exacerbations may require frequent hospitalization. In 2014, Auger, Kahn, Davis, and
Simmons examined hospital readmission among 601 children with asthma between the ages of
1-16. The five year study found that children were more likely to be readmitted if their
caregivers reported any lapse in medication adherence or if they did not answer questions related
to adherence at all.
Costs of hospitalization.
In 2013, Hasegawa, Tsugawa, Brown, and Camargo evaluated the costs of asthma
hospitalizations from 2000-2009. According to the data collected, the costs have increased from
1.3 billion in 2000 to 1.6 billion in 2009. In 2009, there were 305,000 admissions that were an
average of two days. The average cost of hospitalization was $8,406.
Poor Control and Quality of Life
Besides monetary repercussions, poor asthma control has also been shown to have a
negative effect on quality of life in children. Almost half of the children with asthma had missed
school due to their asthma, and 60% of people with asthma limit their physical activity (NCHS,
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2012). In 2013, Li et al. published a study to determine if asthma control affected sleep in 160
children. They found that poor asthma control was also associated with daytime sleepiness.
Summary of Problem
To summarize the concepts presented, the primary problem is that adherence to
medications used to control asthma is poor. Some children do not take any medication at all.
Those who do often fall short of the 80% that is recommended to maintain asthma control.
Children that do not adhere to LTC medications are more likely to have uncontrolled asthma.
Those with uncontrolled asthma are more likely to visit the ED or be hospitalized. This results in
increased costs and decreased quality of life.
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Purpose
The purpose of this research is to determine the different factors that affect adherence to
LTC medications used to manage asthma in children. A literature review was performed to
examine the current evidence. Factors will be identified that either increase or decrease
adherence, and the findings will be discussed.
The secondary purpose of this research is to make recommendations for current practice
and future practice based on the findings in this study. The final purpose of this research is to
make recommendations for future research based on the findings of this study.
Overall, the purpose of this research is identify a method to improve the way that HCPs
care for children with persistent asthma in order to decrease costs and increase the quality of life.

10

Method
A literature review was performed using the CINAHL, ERIC, Medline, Psych Info, and
Academic Search Premier databases. Keywords included asthma AND child* OR pediatric*
AND adherence OR compliance AND corticosteroid* OR “leukotriene modifier*” OR “mast
cell stabilizer*” OR “monoclonal antibod*” OR “long-acting beta agonist.*” This produced a list
of 305 articles. Articles were included only if they met specific criteria.
Articles were included only if the publication was in English. Articles that were written
in foreign languages were excluded. Any duplicate articles were also excluded.
Articles that were published in or after 2010 were included in this review. Articles
published prior to 2010 were excluded.
Primary sources were included in this review. Randomized, controlled trials, controlled
trials without randomization, case-studies, cohort studies, and qualitative studies were included.
Secondary sources were excluded to prevent further degradation of content.
Articles that contributed to the research question were included in this review. Articles
had to identify factors associated with adherence to long-term medications given to control
asthma in children. Articles were excluded if they did not identify specific factors. Articles
were also excluded if they focused on healthcare provider adherence to recommendations.
Articles that included pediatric participants between the ages of 0-18 were included in
this review. Any articles that included adult participants were excluded from this review even if
pediatric participants were also involved in the research.
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Articles that included children diagnosed with asthma were included in this review.
Articles that included children also diagnosed with other diseases were also included in this
review. Articles were excluded if participants had respiratory distress or wheezing, but were not
diagnosed specifically with asthma.
The search yielded 305 results. After apply exclusion criteria 270 articles were
eliminated. The remaining 35 articles were included in the literature review.
Figure 1 Method

305 articles were
identified

91 repeated articles
were eliminated

214 articles remained

4 articles written in
foreign languages
were eliminated

210 articles remained

85 articles that did
not answer the
reserch question were
eliminated

35 articles remained
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Findings
Over 20 factors were identified that affect adherence to LTC medications used to manage
asthma in children. They have been organized into three categories that include internal factors,
external factors, and interventional factors. Inherent characteristics were classified as internal.
Factors that were neither inherent nor controlled by HCPs were classified as external. Factors
that HCPs have control over were classified as interventional.
Internal Factors
Age.
Several different studies have evaluated age and its correlation with adherence to LTC
medications. Studies included various age ranges and populations.
In 2014, Capo-Ramos, Duran, Simon, Akinbami, and Schoendorf examined prescription
fill patterns to ascertain adherence among children with Medicaid. Participants were between the
ages of 2-17, and they were taking LTC medications used to treat persistent asthma. There were
a total of 4,262 participants with the majority being male and white. The researchers determined
that adherence declined over time, and only 15% of the participants were still receiving
medications 190 days after the initial prescription was filled.
Capo-Ramos, Duran, Simon, Akinbami, and Schoendorf (2014) also found that there was
a higher likelihood of non-adherence among toddlers between the ages of 2-4 and adolescents
between the ages of 12-17. Herndon et al. (2012) also found an association between children
between the ages of 2-4 and non-adherence.
Contradictory to these studies, Elkout et al. (2012) showed higher adherence among
children aged 0-4 taking ICS when compared to all other age groups.
13

Koster, Raaijmakers, Vijverberg, and der Zee (2011) evaluated ICS adherence among
children with asthma in the Netherlands between the ages of 4-12. They found that adherence
was higher in the children under the age of six when compared with older children. To
complicate the findings more, Vasbinder et al. (2014) did not show a statistically significant
difference in adherence among children between the ages of 1-11. One weakness in this study
was that participants knew that they were being monitored, and they may have adjusted their
behavior based on this knowledge.
Mosnaim et al. (2014) evaluated adherence to ICSs in 93 minority adolescents between
the ages of 10-16. The average age for adherence greater than 50% was 12. The average age for
adherence less than 50% was 13. This corresponds with data published by Capo-Ramos et al. in
2014 that found an association between older adolescents and non-adherence.
Overall, results vary between the different studies. There is one consistency. That is the
association with older adolescents above the age of 13 and non-adherence. This may be due to
problems with delegation of responsibility which are evaluated later on in this review.
Sex.
Childhood asthma disproportionately affects boys (NCHS, 2012). Most of the studies
included had more male participants, consistent with this unequal distribution.
In 2010, Sawicki et al. evaluated adherence in 425 children with asthma who were
prescribed ICSs. The study spanned five years, and adherence declined over the span of the
study. Adherence was self-reported and classified as consistent, variable, intermittent, or none.
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After the first year it was determined that consistent adherence occurred more frequently in girls.
One limitation was that adherence was self-reported (Schultz et al., 2012).
In 2012, Elkout, Helms, Simpson, and McLay investigated adherence to LTC
medications in 3,172 children with asthma. Adherence to various LTC medications was
determined by medication possession. In this study, adequate adherence was medication
possession between 80-120% of the prescribed regimen. The researchers determined that
adequate adherence was higher in boys for all classes of medication. Overall, 58% of those with
adequate adherence were male. However, 62% of their participants were boys. That is
indicative of higher adherence in girls.
In 2014, Mosnaim et al. examined adherence to ICSs in 93 minority adolescents between
the ages of 10-16. Adherence was determined by medication possession. Their study population
was 44% male. However, only 24% of males had adherence greater than 50%. Data collected in
this study showed that girls were statistically associated with higher adherence.
Herndon et al. (2012) had varying results. They evaluated adherence among 18,456
children with Medicaid using claims data. Higher adherence was found in 60% of the boys
taking ICSs. However, boys accounted for 60% of the participants taking ICSs. They also
evaluated adherence to leukotriene modifiers. Boys accounted for 64% of the participants who
were taking leukotriene modifiers, but they accounted for 64% of the participants with higher
adherence. For leukotriene modifiers boys were slightly more likely to have better adherence.
Overall, there are multiple studies that indicate that adherence in girls is superior to that
of boys with the exception of adherence to leukotriene modifiers.
15

Race/Ethnicity.
In 2011, Koster et al. evaluated ICS adherence among children in the Netherlands
between the ages of 4-12. There were 527 children who participated in the study. Data obtained
determined that good adherence was reported more often in native Dutch children when
compared with other children. One limitation was that adherence was self-reported (Schultz et
al., 2012).
In 2014, Vasbinder et al. also examined adherence to ICSs in children between the ages
of 1-11 in the Netherlands. The purpose of the study was to determine if there were differing
levels of adherence between native Dutch participants and Moroccan participants. They
measured adherence electronically. They found that adherence among the native Dutch was
higher than that of Moroccan children. Adherence among the native Dutch was 56%. The
average adherence for Moroccan participants was 42%.
There have also been studies that evaluate how race and ethnicity affect adherence here in
the United States. Herndon et al. (2012) evaluated adherence among 18,456 children in the
United States using Medicaid claims data. Adherence was lower in the black and Hispanic
participants when compared to white participants. This trend was repeated in the study by CapoRamos et al. in 2014. They evaluated adherence among 4,262 children with Medicaid using
prescription fill patterns. They also found that adherence was lower in the black and Hispanic
participants when compared to the white participants.
Another contributory study by Martin, Olson, Mosnaim, Ortega, and Rothschild (2012)
specifically examined 101 Puerto Rican children with asthma living in the United States.
Overall, adherence was poor. It was determined that 69% of the children in the study did not
16

have well-controlled asthma in the preceding month. However, only 29% of them reported that
they used a medication to control asthma, and had the medication in the house.
The studies consistently showed that adherence is higher in white children when
compared to other races and ethnic backgrounds. Barriers to adherence may be different
depending on the different populations.
External Factors
Socioeconomic status.
In 2012, Elkout et al. examined adherence among 3,172 children with asthma.
Adherence was determined using medication possession. They did find an association between
socioeconomic status and adherence. Socioeconomic status was determined using the Sottish
Index of Multiple Deprivation (SIMD). Results that were between 0-5 indicated low
socioeconomic status, and results that were between 6-10 indicated high socioeconomic status.
Among those with adequate adherence, 54% were of high socioeconomic status. The
lower adherence observed in participants with lower socioeconomic status may be due to the
higher costs associated with asthma. In 2010, Barnett and Nurmagambetov determined that
asthma costs an individual approximately $3,259 annually including $1,680 in medication
expenses.
Environment.
Herndon et al. (2012) also found an association between environment and adherence.
Using Medicaid claims data, they found that among their 18,456 participants 35% of the
participants living in rural areas had poor adherence. Poor adherence among participants living
in urban areas was almost twice as much.
17

Health perception.
Herndon et al. (2012) showed that the higher participants perceived their health the lower
their compliance. This study involved 18,456 children with asthma who were covered by
Medicaid. Capo-Ramos et al. (2014) did not see this trend repeated in their research. They also
evaluated children with asthma who were covered by Medicaid. Their study included 4,262
participants. They found no correlation between health perception and adherence.
Lack of motivation.
In 2014, Vella, Bezzina, and Urpani published data collected in a survey of children with
asthma. There were 131 participants between the ages of 7-15. Among those who reported nonadherence, 76% reported that their lack of adherence was due to indifference. This study differs
from the other studies that incorporate surveys into their research, because it gives the sole
perspective of the older child with asthma, rather than data reported by caregivers.
Parental education.
In 2011, Koster et al. studied 527 children from the Netherlands between the ages of 412. Adherence in this study was self-reported. Results from this study showed that, among
participants that reported good adherence, there was an equal distribution of parents with higher
and lower levels of education. However, they did not specify what was considered a high
education, and what was considered a low level of education. Another weakness was that
adherence levels were reported subjectively (Schultz et al., 2012).
Capo-Ramos et al. (2014) did find an association between adherence and parental
education. They evaluated adherence among 4,262 participants with Medicaid. Continued
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adherence was more likely if parents had at least some college education. Parents were more
likely to discontinue LTC medications if they completed no higher than high-school education.
This was supported by Vasbinder et al. in 2014. Their study included 87 participants in
the Netherlands. Adherence was monitored electronically. Children had higher adherence if
their parents had completed college or university education when compared with children whose
parents had completed no higher than vocational education, 59% and 45% respectively.
Disease/Medication beliefs.
In 2011, Koster, Raaijmakers, Vijverberg, and der Zee evaluated adherence to ICs among
527 children in the Netherlands. They found an association between medication beliefs and
adherence. Among those who reported good adherence, 67% highly believed that the medication
was necessary. One weakness was the use of self-reports (Schultz, 2012). However, this
concept has been reinforced by several other studies.
In 2012, Klok, Kaptein, Duiverman, and Brand examined the effect that medication
beliefs had on electronically monitored adherence among 93 children in the Netherlands between
the ages of 2-6. Overall adherence was high with a median of 92% adherence. They also found
that high adherence was associated with medication beliefs. Parents were more adherent if they
believed two things: the medication was necessary for their child, and there was little risk for
harm.
This concept was also identified by Wijga et al. in 2014. Adherence to LTC medications
was assessed in 229 participants. Reported adherence was higher when parents felt that the
medication was important for their child. However, self-reports were again used (Schultz, 2012).
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Klok, Kaptein, Duiverman, and Brand (2014) observed that parents were more adherent
if they believed that their child needed the medication and the risk of harm was minimal. Nonadherence occurred if parents were concerned about the side effects of the medications. Those
parents would intentionally give their child less medication when symptoms improved.
Schultz et al. (2012) evaluated 132 families, and adherence was electronically monitored.
Parents were interviewed to determine barriers to adherence. Parents in this study reported that
they intentionally stopped administering the medication to see if their child needed it. That
supported previous data that indicated that adherence is improved when parents believe that their
child needs the medicine.
Parental concerns about medications was also determined to affect adherence when
Armstrong, Duncan, Stokes, and Pereira (2014) studied adherence among 43 preschoolers with
asthma in the southern United States. The children included in this study were predominantly
white and male. Adherence was determined using subjective data, and then compared to
prescription fill patterns. Medication beliefs were determined using a questionnaire developed in
prior asthma research. Data obtained showed that negative medication beliefs were associated
with non-adherence. As negative medication beliefs increased adherence decreased.
Vella et al. (2014) assessed adherence among 131 children between the ages of 7-15
taking ICSs. Twenty percent of children who reported non-adherence reported that it was
because they felt the medications were unnecessary. Eighteen percent of the participants also
believed that it was okay to stop the medication in the summer, and an additional 7% reported
that they reduced the dosage. According to Al-Muhsen et al. (2015), these children are three
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times more likely to have uncontrolled asthma, and children with uncontrolled asthma are more
likely to visit the ED. They provided the perspective of the older children, many of whom have
taken responsibility for their own medication administration.
Contradicting all of the previous studies, Vasbinder et al. (2014) did not find an
association with medication beliefs and adherence when they evaluated 87 children with asthma
in the Netherlands. Results from this study did not show statistically significant adherence
among participants whose beliefs ranged from skeptical to accepting.
Overall, most of the included studies emphasized the importance of assessing medication
beliefs when planning care for children with asthma. In 2010, Zedan, Regal, Osman, and Fouda
interviewed the parents of 100 children with asthma. Fifty-three percent of parents were
concerned about medication side effects. HCPs need to educate parents and older children about
the medications that they are taking and overcome this powerful barrier to adherence.
Family dynamics and planning.
In 2012, Schultz et al. published a study in which adherence to ICSs were unknowingly
monitored electronically for 132 children with asthma. Parents that missed doses generally
missed at least half of the prescribed doses. Parents were then asked about their adherence.
Parents then identified reasons for their inconsistency.
The most frequent responses were due to forgetfulness, child refusal, or being too busy.
Some parents reported that their children fell asleep prior to medication administration. Others
reported that medication may not be administered properly when the child is with another

21

caregiver. These concepts identify the importance for the HCP to anticipate these problems, and
assist with problem-solving and planning (Schultz et al., 2012).
In 2014, Klok, Lubbers, Kaptein, and Brand evaluated reasons behind medication
adherence and non-adherence among children with uncontrolled asthma in the Netherlands.
There were 135 families that participated in the study, and children were between the ages of 212. Researchers fist objectively monitored adherence electronically.

Afterwards they

interviewed ten families that had adherence above 75% and ten families with adherence below
75%.
In families with non-adherence there were a lot of the same reasons that have already
been identified. Parents reported that they may forget to give a dose, or skip a dose when their
child refuses it. Among families with higher adherence there was more planning. For example,
parents would create a routine in order to avoid forgetting to give the child their medication
(Klok, Lubbers, Kaptein, and Brand, 2014).
Capo-Ramos et al. (2014) also found an association between children non-adherence and
family dynamics, although their results were different from those that were already discussed.
Single-parent families, with three or more children, had a higher risk for non-adherence when
compared to families that had two parents and less than three children.
This was studied to a lesser extent by Renov in 2014. There were 58 families included
that were taking ICSs. The study found no statistically significant difference in adherence when
comparing single parent families to dual parent families. However, this research did not examine
the number of children in the families.
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Armstrong et al. (2014) did not find a statistically significant correlation between parental
stress and medication adherence when they studied the families of 43 preschoolers with
persistent asthma.
HCPs should anticipate these potential problems. They also need to collaborate with
families and identify any barriers to medication administration. This collaboration can help to
increase adherence (Rohan et al., 2013).
Responsibility.
Klok et al. (2014) objectively monitored medication adherence among 135 children with
asthma between the ages of 2-12. Afterwards they split participants into two groups. One group
had adherence greater than 75%. The other group had adherence less than 75%. Researchers
interviewed the families to determine reasons for non-adherence. They found that many older
children were given the responsibility to take their own medications.
Families with additional stressors gave their children the responsibility at a younger age.
Among the families that had adherence greater than 75% responsibility was given to older
children gradually. Parents also continued to supervise medication administration. In situations
where parental supervision caused conflict they would be more subtle about overseeing their
child’s medication administration (Klok et al., 2014).
Klok et al. (2014) also determined that in families with adherence less than 75% some
parents were unaware of their child’s non-adherence. Others relied on their doctor to intervene.
The data showed that the shift in responsibility from parent to child can be hazardous time for
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medication adherence. It should occur gradually, and parents should resume responsibility if the
child is unable to maintain adherence.
This is supported by Rohan et al. (2013). Adherence among all of the children in the
study improved with the exception of a nine-year old whose parent did not resume responsibility
for medication administration when adherence began to decline. Adherence for this child
continued to decline.
The positive effect of a gradual shift in responsibility is supported by Duncan et al.
(2012). They examined the effectiveness of an intervention used to increase medication
adherence in 48 children with asthma between the ages of 9-15. The purpose of the study was to
determine if the gradual shift in medication responsibility using a teamwork approach between
parents and older children would improve adherence.
Children were divided into three groups. Group one utilized the teamwork intervention
led by therapists. This intervention involved teaching parents and children about development,
independence, expectations, communication, and teamwork. At the beginning of the
intervention children were supervised, and gradually medication responsibility was transferred
depending on their level of adherence. Group two provided an educational intervention in which
families were educated about asthma. Group three was the control group. Over the 20 weeks of
the study adherence declined in all three groups. However, adherence in group one was the
highest. Initially, it was 90%, and it was reduced to a low of 81% after 20 weeks. In group two
adherence was 59%. It was gradually reduced to 33% after 20 weeks. Adherence in the control
group was 67%. It gradually decreased to 37% after 20 weeks. Overall, the teamwork
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promotion intervention resulted in the highest levels of medication adherence. This intervention
shows that adherence can be maintained above 80% when the child gradually assumes
responsibility for medication administration (Duncan et al., 2012).
Severity.
In 2010, Sawicki et al. studied adherence in 425 children with asthma who were
prescribed ICSs. The study spanned five years, and adherence declined over the span of the
study. Adherence was self-reported and classified as consistent, variable, intermittent, or none.
After the first year, consistent adherence was determined to occur more in those with moderate to
severe asthma.
These results were supported by Zhang, Taylor, Sazonov, Thomas, and Price in 2011.
They included 2,220 children with asthma between the ages of 2-14. Adherence was determined
using prescription fill patterns, and it was monitored for a year. Children with mild persistent
asthma had the worst adherence. Fifty-five percent of them had discontinued medication by the
end of the year. Adherence was better in children with moderate persistent asthma, and
adherence was best in children with severe persistent asthma. Only 41% of them had stopped
receiving medication by the end of the year.
These results were replicated by Klok, Kaptein, Duiverman, and Brand in 2014. They
electronically monitored adherence in 81 children with asthma. Overall adherence in this study
was high, between 74-95%. Adherence among children with mild intermittent symptoms was
lowest, 74%. Adherence in children with uncontrolled moderate to severe symptoms was
highest, 95%.
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These studies have all determined that adherence improves as disease severity increases.
This may be because medication is more likely to be perceived as necessary in children who are
more symptomatic.
Exacerbations.
In 2013, Sloan, Gebretsadik, Wu, Michel, and Hartert examined adherence to ICSs
among 51,725 children with asthma covered by Medicaid. During this five-year study,
adherence was determined using prescription fill patterns. The researchers determined that 37%
of ICS were dispensed at the same time that rescue medications were dispensed. Based on this
data, they determined that adherence to LTC medications increased when there was an
exacerbation, and was reactive rather than proactive.
Elkout, Helms, Simpson, and McLay (2012) evaluated adherence to LTC medications
among 3,172 participants. They found an association between higher adherence and those who
obtained greater than six rescue medications annually. Sloan et al. (2013) determined that 37%
of LTC medications were dispensed at the same time that SABAs were dispensed, and adherence
was triggered by an exacerbation. The higher adherence that was observed by Elkout et al. is
likely because children receiving greater than six rescue medications annually have more
exacerbations than those who require less.
Interventional
Caregiver-Family communication.
Communication and problem-solving may contribute to increased adherence to LTC
medications over time. This was demonstrated by Sleath et al, in 2012. They examined 259
children between the ages of 8-16 with persistent asthma. First, they recorded a visit with the
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family and their HCP. They were trying to determine if HCPs complied with national guidelines
that recommend that family input be included when developing a plan of care.
They found that the child’s input was only asked for in 8% of visits and the caregiver’s
input was only asked for in 9% of the visits. A month after the visit the family was interviewed
to assess adherence. Adherence was self-reported. Researchers found that there was statistically
significant higher adherence in the families if HCPs asked for their input when developing the
plan of care (Sleath et al, 2012).
This was also demonstrated by Rohan et al. in 2013. Pediatric psychologists taught HCP
how to provide feedback about ICS adherence and problem-solve with families. Eleven families
were included in the study and children were between the ages of 5-14. Families were divided
into the intervention group in which HCP incorporated their training about adherence feedback
and problem-solving. The other participants were divided into the control group.
In the intervention group, routine asthma care involved feedback about electronically
monitored adherence, identification of barriers to medication administration, and problemsolving. Adherence increased from a baseline adherence of 31% to an intervention adherence of
57%. After completion of the intervention adherence dropped to 26% (Rohan et al., 2013).
Adherence and problem-solving can be an effective tool to increase adherence. This is
supported by Wijga et al., (2014) who reported that parents reported higher adherence when they
felt that had received enough information from their HCP. However, enhanced communication
cannot be used independently to increase adherence above 80%.
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Asthma knowledge.
In 2012, Duncan et al. instilled an educational intervention to determine if it had any
effect on adherence. Participants were between the ages of 9-15 and adherence was
electronically monitored over 20 weeks. In children who received an educational intervention,
adherence gradually declined from 59% to 33%. In the control group, adherence gradually
declined from 67% to 37%. However, the study did not evaluate the knowledge of the
participants.
In 2014, Mosnaim et al. examined adherence to ICSs among minority adolescents with
asthma. There were 93 participants between the ages of 10-16. Adherence was electronically
monitored over two weeks and children were divided into a group that took more than half of
their prescribed medication and a group that took less than half of their prescribed medication.
Children who took more than half of their medication scored higher on a questionnaire used to
determine knowledge about ICSs.
This was also demonstrated by Wijga et al. in 2014. The study included 229 participants
and their families. A questionnaire was used to determine parental knowledge about ICSs.
Reported adherence was 84% for parents who knew that the ICSs should be taken daily.
Reported adherence was only 25% for parents who did not now that the ICSs should be taken
daily. Unfortunately, adherence in this study was self-reported (Schultz et al., 2012).
In 2010, Klok, Brand, Bomhof-Roordink, Duiverman, and Kaptein evaluated adherence
among children with asthma who were going to primary or secondary care facilities. For the
purposes of this study primary care represented a general pediatric facility, and secondary care
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represented a pediatric asthma facility. There were 44 participants, and children were between
the ages of 2-12.
Reported adherence was higher in the secondary group. Parents in the secondary group
believed that the medication was necessary to suppress asthma and prevent exacerbations.
Parents in the primary group believed that the medication would lose its effectiveness if given
regularly. Parents in the secondary group knew more about asthma medications which may
contribute to their increased adherence (Klok, Brand, Bomhof-Roordink, Duiverman, and
Kaptein, 2010).
These studies suggest that knowledge about LTC medications used to manage asthma
may be superior to general asthma knowledge in increasing adherence.
White coat adherence.
Keemink, Klok, and Brand examined white coat adherence in 2014. White coat
adherence is described as adherence that increases in the time period directly preceding a
scheduled visit to the doctor. The study was conducted in the Netherlands, and there were 78
children included.
Participants were between the ages of 2-6 and taking ICSs for asthma. Adherence was
electronically monitored, and the median adherence was 85%. In 22% of the participants
adherence did increase in the week prior to the scheduled outpatient visit. However, adherence
also decreased for 21% of the participants in the week prior to the visit. This study shows that
adherence may increase or decrease directly before a scheduled visit to the doctor (Keemink,
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Klok, and Brand, 2014). White coat adherence can account for the increase. However, there
was no explanation about the decreased adherence.
Specialty care.
In 2010, Klok et al. evaluated adherence among children with asthma who were going to
a general pediatric facility and children who were going to a pediatric asthma facility. There
were 44 participants, and children were between the ages of 2-12. Reported adherence was
higher in the group that went to the asthma clinic.
Bollinger et al. (2013) also evaluated how a specialist may affect adherence. There were
53 participants with persistent asthma included in this study. They were between the ages of 2-8.
The majority of the participants were black. There were more males and most of the participants
had Medicaid. Prescription fill patterns were used to determine adherence. They determined
that 30% of the medications prescribed by the allergist were never filled. However, nonadherence was at least 10% lower in those who saw other HCPs.
Both of these studies suggest that adherence is higher in children who see specialists
rather than primary care providers. However, one study reported that medication knowledge was
higher in the group that saw the specialist (Klok et al., 2010) which may be the main factor
contributing to the increased adherence.
Number of prescriptions.
In 2010, Pando et al. examined adherence to ICSs in children between the ages of 5-15.
There were 2,355 participants in their Canadian study. They determined adherence based on the
amount of medication obtained compared with the amount of medication prescribed. Almost
half of the participants were not prescribed a refill. Among those who were given one
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prescription adherence was 100%. Adherence dropped to 61% for participants who were given
2-6 prescriptions. Those who were given greater than seven prescriptions had the lowest
adherence of 37%.
Based on this study, the higher the amount of prescriptions the lower the adherence. Data
is consistent with other studies that show a gradual decrease in adherence over time. Healthcare
providers should schedule follow-up visits periodically in order to assess adherence, and
determine if there are any barriers or problems with the medications that need to be overcome.
Asthma action plans.
An asthma action plan (AAP) is a written document that is created by a healthcare
provider. It is an individualized medication plan that is either symptom based, peak-expiratory
flow based, or both. Medication instructions are given to the patient and the family dependent on
symptoms or PEF. National guidelines recommend that all patients with asthma receive an AAP.
This plan should be updated at every opportunity (NHLBI, 2007).
In 2011, Ducharme et al. examined how receipt of an AAP affected adherence to ICSs
over 28 days. There were initially 219 participants between the ages of 1-17. The majority of
the participants were white, and there was an even distribution of public and private insurance.
All of the participants were not prescribed ICSs over the entire timespan, and results were based
on the amount of time medications were prescribed.
Participants were divided into two groups. The first group received a prescription and an
AAP. The control group only received a prescription. Adherence was monitored using dose
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counters. Over the course of the 28 days there was higher adherence in the group that received
the asthma action plan, and the gap increased over time.
Over the first two weeks, adherence was 89% for those with the AAP compared to 86%
in the control group. Over the last two weeks adherence was 79% for those with the asthma
action plan compared to 25% for those in the control group (Ducharme et al., 2011). Based on
these results, an AAP may be a key tool in increasing adherence, but it cannot be used
independently to maintain adherence above 80%.
Medication regimens.
There are several studies that suggest that adherence varies depending on medication. In
2011, Zhang, Taylor, Sazonov, Thomas, and Price examined adherence among children with
asthma in the United Kingdom. There were 2,220 children included, and they were between the
ages of 2-14. They used prescription fill patterns to monitor adherence for a year. Adherence
was best for children taking fluticasone. At the end of the year 59% of children were still
receiving medication.
Lesser adherence was observed among children taking beclomethasone. At the end of the
year 45% of children were still receiving this medication. Budesonide had the least adherence.
At the end of the year there were just 42% of children still receiving medication. Out of all of
the included ICSs fluticasone had the best adherence (Zhang, Taylor, Sazonov, Thomas, and
Price, 2011).
Herndon, Mattke, Cuellar, and Hong (2012) examined LTC medication adherence among
18,456 children with asthma. Children were Medicaid recipients and between the ages of 2-18.
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Adherence was determined using prescription fill patterns. Data obtained from this study
showed that medication adherence was higher among children taking leukotriene modifiers when
compared to children taking ICSs. Adherence was 28% for those taking leukotriene modifiers
and 20% for those taking ICS. These results were consistent with those of several other studies.
In 2012, Spray examined adherence to LTC medications among 244 families that had a
child with asthma between the ages of 7-15. Spray also found varying adherence depending on
the type of medication prescribed. Adherence for ICSs was 37%, and adherence for leukotriene
modifiers was 56%.
Elkout et al. (2012) also had similar results when they did a study that evaluated how
medications may affect adherence. Adequate adherence was defined as medication possession of
80-120% of the prescribed regimen. Thirty-nine percent of participants taking leukotriene
modifiers had adequate adherence. Adherence was lower among participants taking LABSs in
conjunction with ICSs. Less than 30% of them had adequate adherence. The worst adherence
was observed among participants taking ICSs as monotherapy. Only 15% had adequate
adherence.
These results replicated by Durcharme, Noya, Allen-Ramey, Maiese, and Blais in 2012.
They used claims data to monitor adherence among 227 children with asthma between the ages
of 2-17. Children included in the study were taking either ICSs or leukotriene modifiers. Fiftyone percent of the prescribed ICSs were claimed. However, 74% of the leukotriene modifiers
were claimed. Once again, there was higher adherence among those taking leukotriene
modifiers.
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Bollinger et al. expanded on this in 2013. They evaluated adherence using prescription
fill patterns for 53 children between the ages of 2-8. They found that 40% of children prescribed
ICSs in conjunction with LABAs never filled their initial prescription. For those prescribed
monotherapy ICSs 31% never filled their initial prescription. Consistent with previous literature,
just 21% of those prescribed leukotriene modifiers did not fill their initial prescription. This data
shows that there is a medication regimen with less adherence than ICSs: ICSs with LABAs.
Capo-Ramos et al. in 2014 also evaluated adherence with different medication
modalities. They included 4,262 children with asthma between the ages of 2-17. Children were
all enrolled in Medicaid, and adherence was determined using prescription fill patterns. They
found that adherence was greater in participants who were prescribed ICSs in conjunction with
leukotriene modifiers when compared to other medications.
Data in these studies provide evidence that the prescribed medication does affect
medication adherence among children with asthma. Adherence is consistently highest for
regimens that contain leukotriene modifiers. Adherence is consistently lowest for monotherapy
ICSs. This represents a difficult situation for HCPs, because ICSs are the most effective
medication for treating persistent asthma (NHLBI, 2007).
Lower adherence for ICSs may be due to negative medication beliefs which do contribute
to non-adherence (Armstrong et al., 2014). Concerns about steroids among the parents of
children with asthma may be as high as 53% (Zedan et al., 2010). That represents a significant
barrier that HCPs will need to anticipate and overcome to improve adherence.
Symptom Diaries
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In 2014, Arga, Sahbaz, Bakirtas, Turktas, and Demirsoy incorporated the use of symptom
diaries into asthma management. There were 340 children between the ages of 6-17 that were
included in the study. They found that children who kept symptom diaries were more likely to
take LTC medications regularly. Eighty-one percent of the children who kept symptom diaries
took medications regularly as opposed to 58% of the children who did not keep symptom diaries.
One significant weakness of this study is that medication adherence was self-reported (Schultz et
al., 2012).
Technology.
In 2012, Feldman et al. evaluated the effect of peak expiratory flow (PEF) feedback
among minority children between the ages of 7-15 living in the Bronx, New York. PEF is an
objective way to monitor lung function. Children received an electronic peak flow device that
gave audible reminders when it was time to check PEF. In the intervention group, children
estimated their PEF prior to using the device, and data was stored. Afterwards, they used their
device and compared their estimate to their actual PEF. Children in the control group were
unable to see their PEF. The entire study included 192 children.
Adherence to ICSs was monitored electronically in 95 of the included children. In the
intervention group that used the electronic peak flow device adherence to ICS was 49%. In the
control group the average adherence was 28%. Incorporating the use of this technology
increased adherence in minority children who had lower rates of adherence when compared to
white children (Feldman et al., 2012).
Giselle et al. (2013) evaluated a different kind of technology in an attempt to improve
medication adherence among minority adolescents between the ages of 11-16 taking ICSs.
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There were 34 participants, and they were divided into an intervention group and a control
group. The intervention group received mp3 players and attended weekly peer group support
meetings. After the meeting, the adolescents recorded supportive messages that were
incorporated into the mp3 playlist. The intervention lasted for 10 weeks.
Adherence gradually declined from baseline in the intervention group and in the control
group. At five weeks adherence for the intervention group was 19%, and adherence for the
control group was 16%. At ten weeks adherence for the intervention group was 7%, and
adherence for the control group was 14% (Giselle et al., 2013).
This technology was not shown to be effective in increasing adherence. There are a
couple of factors that may have contributed. One, in particular, is that the intervention depended
on children listening to the supportive messages on their mp3 players. Children who skipped
over the messages or did not listen to their mp3 players at all would not have benefitted from this
intervention. While this intervention was not successful, there are some more recent studies that
have been able to get better results.
In 2015, Bender et al. conducted a randomized control trial to determine if using voice
recognition phone calls would improve adherence to LTC medications used to manage persistent
asthma. There were 899 participants between the ages of 3-12. Participants were divided into
the intervention group and the control group.
The intervention group received a series of phone calls that were triggered when
medication refills were two weeks overdue. The phone calls reminded parents about the
importance of medications, asked if they needed some assistance with medication refills, and
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also gave them the option of contacting a pharmacist or an asthma nurse with questions. The
control group did not receive phone calls. The study was continued for two years. Adherence
was determined by prescription fill patterns.
Adherence in the control group was 36% and adherence in the intervention group was
45%. The use of voice recognition phone calls did improve adherence, and 84% of parents who
took the survey said that their child’s asthma was better controlled because of the intervention
(Bender et al., 2015).
In 2015, Chan et al. examined adherence to ICS among children between the ages of 6-15
in New Zealand. The researchers conducted a randomized control trial that included 220
participants. Children in the intervention group received an inhaler that had audiovisual
reminders. The inhaler was programmed to know when the LTC medications should be taken.
If the medication was taken within six hours of its scheduled time there was no reminder.
However, if it was not taken a ringtone reminder would play. The ringtone would stop after the
medication was taken or after 15 minutes. Children in the control group did not receive the
electronic reminders.
The average adherence for the intervention group was 84%. The average adherence for
the control group was 30%. Research has shown that children with well-controlled asthma had a
median adherence above 80% (Klok et al., 2014), and this intervention was able to change
behavior enough to achieve those results. This study suggests that technology may play a pivotal
role in changing the way that we manage asthma in the future.
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Summary
A summary of the findings is presented in Table 2.
Table 2 Findings

Internal
Age
Older adolescents have
less adherence
Sex
Females have more
adherence
Race/Ethnicity
Adherence is less among
blacks and Hispanics

External
Socioeconomic Status
Adherence is higher among those
with higher SES
Environment
Adherence is lower in urban areas
Motivation
Indifference contributes to nonadherence
Parental Education
Children whose parents have
higher education have higher
adherence
Disease Beliefs
Adherence is higher if parents
believe that their child needs the
medication for control
Medication Beliefs
Adherence is lower among those
who have negative beliefs about
the medications
Family Dynamics/Planning
Adherence was higher in families
that planned medication
administration and were able to
problem-solve
Responsibility
Adherence was higher among
families that gradually gave
responsibility to older children,
and supervised medication
administration
Severity
The more severe the disease the
higher the adherence
Exacerbations
Adherence increases during an
exacerbation
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Interventional
Communication
Enhanced HCP-family
communication increases
adherence
Medication Knowledge
Knowledge about medications
increases adherence
Doctor Visits
Adherence may increase or
decrease just prior to a scheduled
doctor visit
Specialist
Adherence was increased in those
who saw a specialist
Medications
Adherence is higher among those
prescribed leukotriene modifiers
and lowest among those prescribed
ICSs
Multiple Prescriptions
Adherence declines over time
when multiple prescriptions are
given at once
Asthma Action Plans
AAP increase adherence
Symptom Diaries
Symptom diaries may increase
adherence
Technology
Incorporation of some types of
technology have increased
adherence

Discussion
It is imperative that all children with persistent asthma receive guideline-based care.
However, the internal and external factors identified can help HCPs recognize when additional
barriers can be anticipated. This foresight can enable HCPs to increase adherence and overall
quality of life for children with asthma. It can also lead to reduced costs associated with
emergency care utilization.
Interventional factors identified can help HCPs determine what methods are effective and
what methods are ineffective before making any changes to current practice.
Communication
Multiple studies have concluded that improved communication between families and
HCPs can increase adherence. That is discussed frequently in the subsequent sections.
Time
Multiple studies have suggested that adherence declined over time. One study reported
that the more prescriptions provided initially, the lower the adherence. HCPs should schedule
follow-up appointments to prevent this trend, especially after a new medication regimen is
initiated. During the follow-up HCPs can reassess control, reiterate the importance of the
medications, and also determine if any new barriers have been identified.
Race/Ethnicity
Data reported that there was less adherence among black and Spanish children when
compared to white children. HCPs should anticipate cultural barriers among these populations.
They should anticipate differing perceptions of health and healthcare. For this reason it is
important for HCPs to make sure that families agree with the plan of care. If there are any
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cultural discrepancies HCPs should compromise and work on a plan that everyone can agree on.
HCPs should also anticipate language barriers in families if English is not a first language or not
spoken at all. In these situation a translator should be used.
Socioeconomic Status
The data indicated that medication adherence was lower in families that had a lower SES.
These families may see money as a barrier, and HCPs should know what community resources
are available to help these families with medical expenses as well as transportation to obtain the
prescribed medications.
Urban or Rural Environment
One study reported that adherence was lower in urban areas when compared to rural
areas. This is possibly due to the more established relationship that rural families have with their
HCPs. Communication may be more effective, and better HCP-family communication has been
shown to have a positive effect on adherence. Particularly in urban areas, HCPs should work to
establish relationships with their families and improve communication.
Parental Education
The data also reported that medication adherence was lower in families if parents had
lower levels of education, although some of the data did not specify what was considered lower
levels of education. This may be directly related to SES. If parental education is higher families
are more likely to have higher SES and not perceive money as a barrier. If HCPs determine that
money is preventing families from adhering to medication regimens then they should connect the
family with local resources, as mentioned before. If knowledge and understanding is the reason
for non-adherence then they should provide education.
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Family Dynamics
Family dynamics is about planning. Objective and subjective data was included on this
topic. Families had less adherence if they were single-parent families with at least three kids.
Other families had less adherence if they forgot medication or had problems giving the
medication, such as child refusal. HCPs can help the families plan medication administration
and overcome these barriers. For example, they might suggest that families set an alarm if
forgetfulness is the problem.
Older Adolescents and Responsibility
Some of the data suggested that toddlers had less adherence when compared to older
children. However, there were some studies that did not support this. More data needs to be
obtained to form a conclusion.
The data did consistently point out that older adolescents have less adherence when
compared to younger adolescents and children. Data from subjective studies also found that
adherence declined when parents gave responsibility to older children and adolescents without
supervision. In order to overcome this barrier it is suggested that parents be instructed to
gradually give responsibility to older children and adolescents and to maintain supervision. It is
also important for HCPs to incorporate these children when educating families about medications
and making the treatment plan, because they are also responsible for medication administration.
Motivation and Disease Beliefs
These factors are related, and they can all be affected by the HCP to a certain extent.
Objective and subjective data was obtained for these topics. Children who were not motivated to
take their medications stopped taking them. If parents felt that their child did not need the
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medication they did not give their child the medication. HCPs should determine if these children
do need the medication to obtain control. If they do then HCPs should educate them about how
the medication can improve quality of life and decrease the number of exacerbations.
Understanding may improve motivation and parents may agree that their child does need the
medication.
Medication Knowledge and Beliefs
These factors are also related and can also be affected by the HCP. Objective and
subjective data was also obtained for these topics. Parents in multiple studies expressed
concerns about the medications. Adherence was improved if parents knew more about the
medications. HCPs should anticipate that if families do not have concerns about the medications
they will develop concerns after consulting other sources. That is why HCPs should educate all
families about the medications that they are prescribed even if there are no questions asked.
Many of the parents did not know that LTC medications should be taken regularly rather than
initiated when there is an exacerbation.
Medications
Data from the studies consistently suggest that adherence is higher among medication
regimens that contain leukotriene modifiers and lower among regimens that contain ICSs. That
supports the data obtained from objective and subjective studies that indicate that parents do not
feel comfortable giving their children ICSs. Unfortunately, data also suggests that ICSs are more
effective than leukotriene modifiers. One promising fact is that families with more education
about ICSs did have higher adherence. HCPs should specifically educate families about these
medications, and alleviate any fears or misgivings.
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Severity and Exacerbations
Data suggests that adherence increases during an exacerbation and when children have
more severe asthma. These children are more symptomatic, and families see that the benefits of
administering the medication outweigh the risks. However, HCPs can teach families that it is
possible to prevent these exacerbations and control the symptoms when medication is given
regularly.
Asthma Action Plan (AAP)
Data suggest that AAPs were beneficial in improving adherence. AAPs are
recommended according to national guidelines and should be updated by HCPs at every
opportunity.
Specialist or Primary Care
Data suggests that adherence improved when families went to a specialist rather than a
general pediatric practitioner. Also, one subjective study reported that knowledge about the
medications was also greater if families went to a specialist. The increased adherence may be
because parents were more knowledgeable about the medications which has also been shown to
increase adherence. HCPs in any setting should ensure that families are knowledgeable about
their medications and plan of care.
Symptom Diary
Data suggests that symptom diaries were beneficial in improving adherence. However,
the only data available was based on self-report. It is recommended that more data be obtained
before incorporating symptom diaries into patient care.
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Technology
Peak flow meters that electronically measured peak expiratory flow after an estimate
were reported to have a positive effect on adherence. MP3 players with recorded messages
providing encouragement did not have a positive effect on adherence. Data reported that voice
recognition phone call reminders and inhalers with electronic monitors did have a positive effect
on adherence. HCPs should incorporate technology into current practice if it is practical.
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Recommendations for Current Practice
It is recommended that HCPs in inpatient and outpatient settings incorporate this fourstep process into management of children with persistent asthma to overcome the majority of the
barriers that have been identified. To ensure that all of these steps occur routinely it may be
beneficial to use a prompting form. An example of a prompting form can be found in the
appendix.
1. Assess and Educate
In this step, HCPs should assess asthma severity and control using guidelines established
by the NHBLI. They should also assess knowledge about previously prescribed LTC
medications and administration technique if applicable. HCPs should also assess adherence to
LTC medications used to control persistent asthma. If relying on patient or caregiver report,
HCPs should assume that adherence is over-reported. If patients that are prescribed LTC
medications have poor asthma control, HCPs should assume that poor adherence is a factor.
They should also assess for any barriers that may contribute to poor adherence. As HCPs are
assessing, they should also be educating, if appropriate.
2. Collaborate
This step includes planning or revising a current plan. This is where the asthma action
plan can be created. HCPs should collaborate with the families when making the plan because
parents consider themselves to be the ultimate decision makers when it comes to caring for their
children. If older children or adolescents are responsible for medication administration, they
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should be included in creating the plan. HCPs should compromise if there are any
disagreements.
3. Problem-Solve
In the first two steps, barriers to adherence may be identified by families. In the third
step, problem solving should be incorporated into the plan. Identify possible solutions to any
obstacles that have been identified. It may be helpful to write this out for parents to reference
later. Know the local resources available for parents who cannot afford medications or do not
have transportation to pick up medications.
4. Follow-up
Anything can happen after the family leaves. That is why it is important for HCPs to
make follow-up appointments at the time of the visit. Adherence may decline after the visit for
innumerable reasons, and it is recommended that adherence be assessed regularly. Also, a
follow-up appointment is necessary for HCPs to determine if the prescribed regimen is effective.
By using these four steps collectively HCPs can potentially overcome most of the barriers
to adherence that were identified in this review of literature.
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Recommendations for Future Practice
In the future, it is recommended that HCPs use data obtained from electronic inhalers to
objectively monitor adherence rather than relying on reported adherence to modify plans. The
reasoning is simple. If asthma control is poor, and medication adherence is also poor, changing
the medication regimen is not going to solve the problem. In order to determine if adherence is
the problem, HCPs need to be able to monitor adherence objectively.
Electronic inhalers are more expensive than traditional inhalers. However, the objective
data obtained from the electronic inhalers can help HCPs identify that there are barriers to
medication adherence even if the families do not readily communicate this. HCPs could use this
information to possibly identify barriers to adherence. If they are able to improve adherence
asthma control will improve as will quality of life. Costs from asthma care will also decrease.
Overall, the benefits outweigh the costs.
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Recommendations for Future Research
This review has identified different factors that affect adherence to LTC medications used
to manage asthma in children. However, it has not effectively determined why all of these
factors affect adherence. Future research should evaluate this.
It is recommended that some of the studies presented be repeated to validate the results.
A study should be done to see if symptom diaries improve adherence when adherence is
monitored objectively rather than through self-report. It is also recommended that the study that
incorporates inhalers that use audio and visual reminders be repeated on a larger scale and with
various demographics to make the results more generalizable.
Future research should also evaluate the effectiveness of using the suggested four-step
plan to improve adherence to medications.
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Limitations
Many research studies excluded participants who did not speak English. This is a
limitation because non-adherence caused by cultural or language barriers may be overlooked
because those participants were excluded. Also, each study included had its own unique criteria
for inclusion. Some studies focused specifically on minorities while other studies focused
primarily on the Medicaid population. This increased the generalizability, but it decreased the
strength of the comparisons.
Another limitation is that the different studies also had varying measurements of
adherence. One study may define adequate adherence as greater than 48% whereas another
study may define adequate adherence as greater than 80%. In many studies adherence was
determined based on prescription fill patterns. One weakness to that is that receipt of medication
does not guarantee administration of the medication. Adherence is likely over-reported in those
studies.
Another limitation is that different studies also defined statistical significance differently.
One study may have described statistically significant data as p=<0.05, and another study may
described it as p=<0.01. This decreased the strength of the comparisons as well.
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Appendix: Example of a Prompting Form That Can Be Used by Healthcare
Providers Caring for Children With Asthma
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